IP Library › Assignment 020054/0484
Patent Assignment
Reel/Frame 020054/0484

Merger

Recorded: 2007-11-01 Pages: 10
Assignor
NEW RIVER PHARMACEUTICALS INC.
Executed: 2007-10-26
Assignee
SHIRE LLC
9200 BROOKFIELD COURT, FLORENCE, KENTUCKY, 41042
Covered Properties (30)
Iodothyronine Polymers
Patent: 5,767,227 →
Application: 08/347,104 →
Iodothyronine Polymers
Patent: 5,910,569 →
Application: 08/917,098 →
Stabilized Thyroxine Compounds
Patent: 6,627,660 →
Application: 09/440,635 →
Active Agent Delivery Systems and Methods for Protecting and Administering Active Agents
Patent: 6,716,452 →
Application: 09/642,820 →
Pharmaceutical Composition Containing an Active Agent in an Amino Acid Copolymer Structure
Patent: 7,018,654 →
Application: 09/986,426 →
Publication: US 2002/0128177
Iodothyronine Compositions
Patent: 7,163,918 →
Application: 10/136,433 →
Publication: US 2004/0087483
Active Agent Delivery Systems and Methods for Protecting and Administering Active Agents
Patent: 7,060,708 →
Application: 10/156,527 →
Publication: US 2004/0063628
Controlled absorption of admixed thyroid hormone formulations
Application: 10/701,173 →
Publication: US 2004/0152783
Abuse Resistant Lysine Amphetamine Compounds
Patent: 7,223,735 →
Application: 10/857,619 →
Publication: US 2005/0038121
Abuse-Resistant Amphetamine Compounds
Patent: 7,105,486 →
Application: 10/858,526 →
Publication: US 2005/0054561
Dendritic Encapsulation of Active Agents
Patent: 7,438,900 →
Application: 10/885,878 →
Publication: US 2005/0069550
Active Agent Delivery Systems and Methods for Protecting and Administering Active Agents
Patent: 7,427,600 →
Application: 10/923,088 →
Publication: US 2007/0232529
Use of peptide-iodothyronine conjugation to reduce inter-subject variability of drug serum levels
Application: 10/923,089 →
Publication: US 2005/0065086
Sustained Release Pharmaceutical Compounds to Prevent Abuse of Controlled Substances
Patent: 7,622,441 →
Application: 10/923,257 →
Publication: US 2005/0080012
Abuse-Resistant Hydrocodone Compounds
Patent: 7,338,939 →
Application: 10/953,110 →
Publication: US 2005/0266070
Abuse-Resistant Hydrocodone Compounds
Patent: 7,375,082 →
Application: 10/953,116 →
Publication: US 2005/0176645
Pharmaceutical Compositions for Prevention of Overdose or Abuse
Patent: 7,375,083 →
Application: 10/953,119 →
Publication: US 2005/0176646
Compounds and Compositions for Prevention of Overdose of Oxycodone
Patent: 7,169,752 →
Application: 10/955,006 →
Publication: US 2005/0176644
Pharmaceutical Compositions for Prevention of Overdose or Abuse
Application: 11/089,056 →
Publication: US 2006/0014697
Carbohydrate Conjugates to Prevent Abuse of Controlled Substances
Patent: 8,133,881 →
Application: 11/179,801 →
Publication: US 2007/0197451
Synergistic effects of combined administration of mirtazapine and a stimulant compound
Application: 11/268,529 →
Publication: US 2006/0100136
Pharmaceutical compositions for prevention of overdose or abuse
Application: 11/392,878 →
Publication: US 2007/0060500
Abuse-Resistant Amphetamine Prodrugs
Patent: 7,700,561 →
Application: 11/400,304 →
Publication: US 2007/0042955
Prodrugs of T3 and T4 with enhanced bioavailability
Application: 11/517,582 →
Publication: US 2007/0099841
Compounds and Compositions for Prevention of Overdose of Oxycodone
Patent: 8,106,016 →
Application: 11/635,788 →
Publication: US 2007/0203055
Prodrugs of Ribavirin with Improved Hepatic Delivery
Application: 11/718,311 →
Publication: US 2008/0260691
Abuse Resistant Lysine Amphetamine Compounds
Patent: 7,662,787 →
Application: 11/745,019 →
Publication: US 2008/0086016
Pharmaceutical Compositions of Hydromorphone for Prevention of Overdose or Abuse
Application: 11/868,283 →
Publication: US 2008/0207668
Abuse-Resistant Hydrocodone Compounds, Compositions and Methods of Using the Same
Application: 11/868,636 →
Publication: US 2008/0090771
Pharmaceutical compositions of hydromorphone for prevention of overdose or abuse
Application: 60/849,774 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 6, 1997
From: INOVAR CHEMICALS, INC.
To: LOTUS BIOCHEMICAL CORPORATION
Reel/Frame 008293/0775 →
Assignment of Assignor's Interest Jan 12, 2000
From: PICCARIELLO, THOMAS; LECLERCQ, ANNE F.
To: LOTUS BIOCHEMICAL CORPORATION
Reel/Frame 010523/0520 →
Change of Name Jul 20, 2000
From: LOTUS SPINCO CORPORATION
To: LOTUS BIOCHEMICAL CORPORATION
Reel/Frame 010984/0400 →
Bill of Sale Jul 20, 2000
From: LOTUS BIOCHEMICAL CORPORATION
To: LOTUS SPINCO CORPORATION
Reel/Frame 010984/0403 →
Assignment of Assignor's Interest Jan 4, 2001
From: PICCARRIELLO, THOMAS; OLON, LAWRENCE P.; KIRK, RANDALL J.
To: LOTUS BIOCHEMICAL CORPORATION
Reel/Frame 011401/0605 →
Assignment of Assignor's Interest Jul 17, 2003
From: PICCARIELLO, THOMAS; KIRK, RANDAL J.; OLON, LAWRENCE PETER
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 014286/0851 →
Change of Name Jul 29, 2003
From: LOTUS BIOCHEMICAL CORPORATION
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 014328/0815 →
Assignment of Assignor's Interest Aug 6, 2003
From: PICCARIELLO, THOMAS; MONCRIEF, JAMES SCOTT; OLON, LAWRENCE PETER; BOERTH, NANCY JOHNSTON
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 014354/0318 →
Change of Name Oct 27, 2003
From: LOTUS BIOCHEMICAL CORPORATION
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 014631/0708 →
Change of Address for Assignee, Previously Recorde Feb 5, 2004
From: NEW RIVER PHARMACEUTICALS INC.
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 014954/0683 →
Assignment of Assignor's Interest Apr 19, 2004
From: LOTUS BIOCHEMICAL CORPORATION
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015236/0467 →
Assignment of Assignor's Interest Apr 19, 2004
From: LOTUS BIOCHEMICAL CORPORATION
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015232/0631 →
Change of Name Apr 19, 2004
From: LOTUS BIOCHEMICAL CORPORATION
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015232/0594 →
Assignment of Assignor's Interest Apr 20, 2004
From: OLON, LAWRENCE PETER; MONCRIEF, JAMES SCOTT; BOERTH, NANCY JOHNSTON; PICCARIELLO, THOMAS
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015237/0449 →
Assignment of Assignor's Interest Oct 26, 2004
From: MICKLE, TRAVIS; LAUDERBACK, CHRISTOPHER; PICCARIELLO, THOMAS; KRISHNAN, SUMA
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015928/0071 →
Assignment of Assignor's Interest Oct 26, 2004
From: MICKLE, TRAVIS; LAUDERBACK, CHRISTOPHER; PICCARIELLO, THOMAS; KRISHNAN, SUMA
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 015928/0112 →
Assignment of Assignor's Interest Dec 2, 2004
From: KIRK, RANDAL; PICCARIELLO, THOMAS
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016035/0920 →
Assignment of Assignor's Interest Dec 13, 2004
From: MICKLE, TRAVIS; KRISHNAN, SUMA; LAUDERBACK, CHRISTOPHER; MONCRIEF, JAMES SCOTT
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016074/0492 →
Assignment of Assignor's Interest Dec 13, 2004
From: PICCARIELLO, THOMAS; MICKLE, TRAVIS; BISHOP, BARNEY
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016067/0772 →
Assignment of Assignor's Interest Dec 30, 2004
From: MICKLE, TRAVIS; KRISHNAN, SUMA; LAUDERBACK, CHRISTOPHER; MONCRIEF, JAMES SCOTT
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016132/0523 →
Assignment of Assignor's Interest Dec 30, 2004
From: MICKLE, TRAVIS; KRISHNAN, SUMA; LAUDERBACK, CHRISTOPHER; MILLER, CHRISTAL
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016114/0417 →
Assignment of Assignor's Interest Jan 5, 2005
From: MICKLE, TRAVIS; MONCRIEF, JAMES SCOTT; HIRSCHELMAN, WENDY; KRISHNAN, SUMA
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016125/0365 →
Assignment of Assignor's Interest Jan 12, 2005
From: MICKLE, TRAVIS; MONCRIEF, JAMES SCOTT; KRISHNAN, SUMA; PICCARIELLO, THOMAS
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016149/0009 →
Assignment of Assignor's Interest Feb 11, 2005
From: PICCARIELLO, THOMAS; KIRK, RANDAL J.; MICKLE, TRAVIS
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016252/0158 →
Assignment of Assignor's Interest Feb 16, 2005
From: MICKLE, TRAVIS; MONCRIEF, JAMES SCOTT; KRISHNAN, SUMA; MILLER, CHRISTAL
To: NEW RIVER PHARMACEUTICALS INC.
Reel/Frame 016277/0244 →